Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...
Capital Markets Day presentations highlight opportunities and potential based on Elekta's strong position STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, ...
Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system ...
Elekta has announced the introduction of its latest linear accelerator (linac), Evo, to the Indian market. Already launched in Europe and other regions, Evo is now available in India, bringing ...
GUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo ...
GE HealthCare has partnered with radiation therapy company Elekta to develop new software to improve clinicians experience and enable greater precision treatment. Elekta will use GE HealthCare’s MIM ...
Mary Bird Perkins Cancer Center is launching a $10 million adaptive radiation therapy program that uses a technology designed in Sweden to enhance the precision of radiation doses, the organization ...
STOCKHOLM, Sept 27 (Reuters) - Radiation therapy equipment company Elekta is targeting annual sales growth of 8-10 percent based on constant exchange rates through to its 2022/2023 financial year, ...
GE HealthCare extends its collaboration with Elekta, a leader in radiation therapy, in the Indian market, to expand access to precision radiation therapy solutions. It aims to provide hospitals with a ...
STOCKHOLM, Aug 25 (Reuters) - Radiation therapy equipment maker Elekta EKTAb.ST reported on Wednesday a slump in its first-quarter earnings due to higher costs in its supply chain and logistics. The ...
STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, ...